Capes
CAPES (Child and Adolescent Program Enrichment Services) is a team of independently practicing health care experts committed to changing the service delivery system by providing collaborative care recommendations to families for children and adolescents with complex medical, psychological, and developmental problems.
ICO
264083427
Web
Sign in to see organisation website
Address
Tulsa
From Social media
News about from their social media (Facebook and X).
Data about organisation
Tulsa
Organisations from Capes
Message me " Shallow " for "Shallow Christianity" the Hebrews Study Guide.
2. ALZHEIMERS DISEASE AND RELATED DISORDERS ASSOCIATION
The Alzheimer's Association 24/7 Helpline provides reliable information and support to all those who need assistance.
3. Aldersgate United Methodist Church
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
4. TULSA FAITH UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
5. HOPE UNITED METHODIST CHURCH
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.
Interesting nearby
Interesting organisations close by to residence of Capes
Horse Feathers Equine Center Inc
501(c)(3) NonProfit focused on rehab of equines, education for the community on equine care.
Association of Catholic Counselors
A professional association for Catholic Counselors.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Exciting news from ITM! 🚀 Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! 💪💙 #CancerResearch #Hope #PositiveNews
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025
StreetInsider.com
Like Comment